School of Medicine Distinguished Lecture Series featuring Alejandro Sweet-Cordero, MD
Wednesday, March 13, 2024 / 12:00 to 1:00 p.m.
CHI Health Creighton University Medical Center Bergan Mercy
7710 Mercy Road, Room 11661 A, B, and C Omaha, NE 68124
Image
Emerging Trends in Precision Cancer Care: The UCSF Experience
Objectives
- Identify the main categories of findings that can be identified by tumor sequencing
- Review a mutational signature and how might it be clinically relevant
- Explore the difference between using real world data and clinical trial data in oncology research.
Designed For
Physicians, physicians assistants, nurses, nurse practitioners, residents, fellows and students
Provided By
- Creighton University School of Medicine
- Creighton University Office of Continuing Education
Wednesday, March 13, 2024
Noon-1 p.m. CT
10 a.m.-11 a.m. MT
In-Person at:
CHI Health Creighton University
Medical Center Bergan Mercy
Room 11661A, B and C
7710 Mercy Road
Omaha, NE68124
Click Here to View Online
For those attending virtually, this program will be available through Zoom. Scroll down under Featured Activities to find the DLS activity.
No Cost | 1.0 CE Hours
Image
Image
Image
Alejandro Sweet-Cordero, MD
Benioff UCSF Professorship in Children's Health, UCSF
Chief of Pediatric Oncology, Department of Pediatrics, UCSF
Director, Molecular Oncology Initiative & Co-Leader, Pediatric Malignancies Program, UCSF Helen Diller Family Comprehensive Cancer Center
Presented by Alejandro Sweet-Cordero, MD
Dr. Alejando Sweet-Cordero cares for children with cancer. He specializes in treating patients with sarcomas (a type of cancer that originates in bone or soft tissue) and in treating advanced cancers through precision medicine (the use of a patient's genetic data to optimize therapy).
In research, Sweet-Cordero has two areas of focus. First, he studies ways to use gene sequencing data from tumors to inform treatment decisions. Specifically, he directs the UCSF Molecular Oncology Initiative, which uses such data in determining the best treatments for relapsed, growing or other difficult-to-treat cases. Second, he runs a research lab dedicated to finding new therapies for sarcomas, particularly osteosarcoma and Ewing's sarcoma.
Sweet-Cordero earned his medical degree at UCSF, where he also completed a residency in pediatrics. He completed a fellowship in pediatric oncology at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center.
A native Spanish speaker, Sweet-Cordero enjoys working with Spanish-speaking patients and their families. He appreciates the diversity of UCSF's patient population and how it reflects the Bay Area's cultural diversity. In his free time, he enjoys spending time with family and friends, cooking and reading.
Education Credit
Category 1
Creighton University Health Sciences Continuing Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.
Physicians should claim only credit commensurate with the extent of their participation in the activity.
Nurse CE
Creighton University Health Sciences Continuing Education designates this activity for 1.0 contact hour for nurses. Nurses should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
In support of improving patient care, Creighton University Health Sciences Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Image
Topics: